ADC Review / Journal of Antibody-Drug Conjugates (Blogs)


ADC Review / Journal of Antibody-Drug Conjugates (Blogs)

ADC Review / Journal of Antibody-drug Conjugates is an international publication combining social media with an online-only, hybrid open access peer reviewed journal. 

The Journal reviews and discusses the ongoing research and development associate with antibody-drug conjugates (ADCs).  Published articles cover biological, pharmaceutical, environmental, chemical, production, industrial manufacturing, legal/regulatory, clinical trial and medical/treatment aspects of ADCs. 

Publishing Team

Peter Hofland, PhD | Publisher and Executive Editor
Martijn Pierik | Associate Publisher
Nick Richardson | Business Development Manager 

Key Objective

To rapidly disseminate and elucidating basic understanding as well as fundamental mechanisms,  clinical application and medical use associated with ADC.

Critical Objectives

  • Maintain the highest standards of editorial integrity independent of any special interests
  • Publish original, important, valid, peer-reviewed articles
  • Foster responsible and balanced debate
  • Inform readers about the all aspects and issues related to Antibody-drug Conjugates
  • Achieve the highest level of  medical ethical journalism
  • Publish a publication that is timely, credible, and enjoyable to read
  • Implement technologies to drive innovation and improve the communication of the journal's content.

ISSN: 2327-0152

Members: 2
Latest Activity: Sep 4, 2013

Discussion Forum

This group does not have any discussions yet.

ADC Review / Journal of Antibody-Drug Conjugates (Blogs)

Loading… Loading feed

Comment Wall


You need to be a member of ADC Review / Journal of Antibody-Drug Conjugates (Blogs) to add comments!


Members (2)


Register for free to view all the Onco'Zine - The International Oncology Network content:


Onco'Zine is present here

Bookmark / Share



© 2017   Created by Peter Hofland, PhD.   Powered by

Badges  |  Report an Issue  |  Terms of Service

Find us on Google+